Human Mesenchymal Stem Cell Culture
Human mesenchymal stem cells cultured in a nutrient medium for therapeutic applications in regenerative medicine, such as treating joint injuries or autoimmune diseases. These cells are classified under tariff item 3002.59.00 as other modified cell cultures for therapeutic uses.
Import Duty Rates by Country of Origin
| Origin Country | MFN Tariff | Surtaxes | Total Effective Rate |
|---|---|---|---|
| 🇨🇳China | Free | — | Free |
| 🇲🇽Mexico | Free | — | Free |
| 🇺🇸United States | Free | — | Free |
| 🇩🇪Germany | Free | — | Free |
| 🇯🇵Japan | Free | — | Free |
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
If the stem cells are unmodified and used for research purposes.
Unmodified cells may be classified under other headings for blood products.
Not sure which classification is right?
The Tariff Assistant works through the GRI rules on your specific product to reach the right tariff item — and can price the duty on it in the same conversation.
Import Tips & Compliance
• Prepare a detailed description of the cell culture medium and any additives, as these may affect classification
• Ensure compliance with Health Canada regulations for human cells for therapy
• Keep documentation of the cells' intended therapeutic use to support the tariff classification
Related Products under Tariff item 3002.59.00
CHO Cell Culture for Protein Expression
Genetically modified Chinese hamster ovary (CHO) cells cultured for the production of recombinant therapeutic proteins such as insulin analogs. These cells are classified as other modified cell cultures for therapeutic uses under tariff item 3002.59.00.
HEK293 Cell Culture
Human embryonic kidney 293 (HEK293) cells cultured for viral vector production in gene therapy applications. These cells are classified as other modified cell cultures for therapeutic gene delivery uses under tariff item 3002.59.00.
Human Keratinocyte Cell Culture
Epidermal keratinocytes cultured for skin graft therapies in burn treatment and wound healing. These human cell cultures are biotechnologically expanded for clinical applications and fall under tariff item 3002.59.00 as other cell cultures.
Human Neural Progenitor Cell Culture
Progenitor cells from human neural tissue expanded in culture for neurodegenerative disease therapies like Parkinson's. These cells are classified under tariff item 3002.59.00 as other cell cultures modified biotechnologically for therapeutic uses.
iPSC-Derived Cardiomyocyte Cell Line
Induced pluripotent stem cell (iPSC)-derived cardiomyocytes grown in specialized media for cardiac repair therapies and drug toxicity testing. These cells are classified under tariff item 3002.59.00 as modified cell cultures for therapeutic uses.
Murine T-Cell Hybridoma Culture
Hybridoma cell lines from mouse T-cells cultured for producing immunological products like cytokines in cancer immunotherapy. These cells are classified under tariff item 3002.59.00 as other animal cell cultures for therapeutic uses.